ANIP
NASDAQ
$77.72
ANI Pharmaceuticals Inc (ANIP)
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
Sector:
Healthcare
Strong Buy
Target: $110 (+41.53%)
Market Cap
$1.69B
PEG Ratio
0.01
EPS 5Y CAGR
+25.74%
Revenue 5Y CAGR
+34.07%
Price Chart
Valuation
Market Cap$1.69B
P/E20.37
Forward P/E9.59
PEG0.01
P/S2.02
P/B3.27
Profitability
Total Revenue (TTM)$924M
Gross Profit (TTM)$562M
EBITDA$213M
Profit Margin12.4%
Operating Margin16.4%
EPS$3.97
Financial Health
Debt-to-Equity54.3%
Free Cash Flow Yield11.31%
Growth & Risk
EPS 5Y CAGR+25.74%
Revenue 5Y CAGR+34.07%
FCF 5Y CAGR+45.89%
Beta (5Y)0.60
Sharpe Ratio0.44